Lonza acquiring smaller peptide players, or Carlyle investing in Bachem) to capture GLP-1 growth ( [50] ) ( [13] )
Best overall meal replacement shake Serving size: 12 fl
Technology Advancement Impact Innovations in microencapsulation and nanoemulsion technologies have significantly improved stability and bioavailability
Studies highlight its potential for joint pain relief, improved blood flow, and neuroprotection after injuries like strokes
Dysesthesia, an abnormal sensation often described as tingling, burning, or numbness in the skin, appeared in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose, compared to just 0.7% on placebo
Current Developments in Nutrition